VThunter
a database for single-cell screening of virus target cells in animal kingdom
Turtle

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Trachemys; Trachemys scripta,

Latin Name: Trachemys scripta elegans

Tested tissues: Pallium,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_110083 2018.05 Drop-seq Pallium Normal 18828 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Dengue virus
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Pallium-tsEG : 20.92% ;
Adeno-associated virus - 2
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsExc5 : 23.49% ;
Pallium-tsExc1 : 23.09% ;
Pallium-tsOlig : 18.71% ;
Pallium-tsExc2 : 18.39% ;
Pallium-tsExc3 : 17.58% ;
Adeno-associated virus - 3
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Adeno-associated virus 9
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Adeno-associated virus - 8
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Venezuelan equine encephalitis virus
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Sindbis virus
Pallium-tsLeuB : 97.22% ;
Pallium-tsLeuT : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Classical swine fever virus
Pallium-tsLeuT : 97.22% ;
Pallium-tsLeuB : 97.22% ;
Pallium-tsMG : 90.32% ;
Pallium-tsExc1 : 84.96% ;
Pallium-tsNPCs : 81.73% ;
Simian rotavirus A strain RRV
Pallium-tsExc1 : 95.13% ;
Pallium-tsExc3 : 93.42% ;
Pallium-tsExc4 : 93.19% ;
Pallium-tsExc5 : 92.44% ;
Pallium-tsExc2 : 92.36% ;
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsEG : 26.90% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsLeuT : 11.11% ;
Pallium-tsMG : 9.85% ;
Hepacivirus C
Pallium-tsExc4 : 93.49% ;
Pallium-tsExc3 : 92.95% ;
Pallium-tsExc1 : 91.31% ;
Pallium-tsExc5 : 88.55% ;
Pallium-tsEG : 84.17% ;
Pallium-tsMur : 35.09% ;
Pallium-doublets : 12.80% ;
Pallium-tsEG : 20.92% ;
Pallium-tsMG : 19.52% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsOlig : 14.19% ;
Pallium-doublets : 13.41% ;
Pallium-tsLeuT : 11.11% ;
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Pallium-tsExc3 : 9.68% ;
Pallium-tsExc1 : 11.44% ;
Human papillomavirus type 16
Pallium-tsOlig : 87.74% ;
Pallium-tsEG : 33.67% ;
Pallium-tsExc2 : 27.18% ;
Pallium-tsInh2 : 21.84% ;
Pallium-tsExc1 : 21.82% ;
Pallium-tsEG : 66.50% ;
Pallium-tsExc2 : 26.60% ;
Pallium-tsNPCs : 24.55% ;
Pallium-tsLeuB : 22.22% ;
Pallium-tsInh1 : 20.82% ;
Porcine reproductive and respiratory syndrome virus
Pallium-tsOlig : 87.74% ;
Pallium-tsEG : 33.67% ;
Pallium-tsExc2 : 27.18% ;
Pallium-tsInh2 : 21.84% ;
Pallium-tsExc1 : 21.82% ;
Rabies lyssavirus
Pallium-tsExc2 : 85.63% ;
Pallium-tsExc3 : 84.68% ;
Pallium-tsExc4 : 79.99% ;
Pallium-tsInh2 : 79.52% ;
Pallium-tsExc5 : 79.34% ;
Pallium-tsExc1 : 42.37% ;
Pallium-tsExc3 : 30.36% ;
Pallium-tsExc5 : 19.83% ;
Pallium-tsExc4 : 18.09% ;
Pallium-tsInh2 : 22.44% ;
Pallium-tsMur : 12.28% ;
Bovine leukemia virus
Pallium-tsExc1 : 81.99% ;
Pallium-tsExc5 : 74.91% ;
Pallium-tsExc4 : 72.22% ;
Pallium-tsExc3 : 71.62% ;
Pallium-tsExc2 : 69.95% ;
Chikungunya virus
Pallium-tsExc1 : 77.97% ;
Pallium-tsExc5 : 67.77% ;
Pallium-tsExc3 : 64.76% ;
Pallium-tsExc4 : 64.52% ;
Pallium-tsInh2 : 61.90% ;
Pallium-tsMur : 40.35% ;
Pallium-doublets : 11.59% ;
Enterovirus A71
Pallium-tsOlig : 71.61% ;
Pallium-tsExc2 : 25.62% ;
Pallium-tsExc5 : 23.73% ;
Pallium-tsInh2 : 23.49% ;
Pallium-tsEG : 21.65% ;
Coxsackievirus A16
Pallium-tsOlig : 71.61% ;
Pallium-tsExc2 : 25.62% ;
Pallium-tsExc5 : 23.73% ;
Pallium-tsInh2 : 23.49% ;
Pallium-tsEG : 21.65% ;
Human immunodeficiency virus 2
Pallium-tsEG : 63.74% ;
Pallium-tsLeuB : 38.89% ;
Pallium-tsLeuT : 22.22% ;
Pallium-doublets : 17.07% ;
Pallium-tsOPC : 11.55% ;
Pallium-tsLeuT : 11.11% ;
Human immunodeficiency virus 1
Pallium-tsEG : 63.74% ;
Pallium-tsLeuB : 38.89% ;
Pallium-tsLeuT : 22.22% ;
Pallium-doublets : 17.07% ;
Pallium-tsOPC : 11.55% ;
Pallium-tsLeuT : 11.11% ;
Feline immunodeficiency virus
Pallium-tsEG : 63.74% ;
Pallium-tsLeuB : 38.89% ;
Pallium-tsLeuT : 22.22% ;
Pallium-doublets : 17.07% ;
Pallium-tsOPC : 11.55% ;
Influenza A virus
Pallium-tsExc1 : 59.11% ;
Pallium-tsOlig : 56.13% ;
Pallium-tsMur : 50.88% ;
Pallium-tsExc5 : 46.81% ;
Pallium-tsExc3 : 42.76% ;
Pallium-tsExc3 : 43.98% ;
Pallium-tsExc1 : 43.86% ;
Pallium-tsExc2 : 40.23% ;
Pallium-tsExc4 : 38.88% ;
Pallium-tsExc5 : 36.95% ;
Pallium-tsMur : 35.09% ;
Pallium-doublets : 12.80% ;
Pallium-tsExc1 : 32.63% ;
Pallium-tsExc5 : 27.10% ;
Pallium-tsExc4 : 25.49% ;
Pallium-tsExc3 : 25.09% ;
Pallium-tsExc2 : 21.84% ;
Ebola virus
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Zika virus
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Lassa mammarenavirus
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Pallium-tsOlig : 56.77% ;
Pallium-tsExc1 : 50.00% ;
Pallium-tsExc5 : 41.74% ;
Pallium-tsExc4 : 38.18% ;
Pallium-tsExc3 : 38.06% ;
Pallium-tsEG : 21.31% ;
Pallium-tsExc1 : 20.13% ;
Pallium-tsExc5 : 15.11% ;
Pallium-tsExc2 : 13.46% ;
Pallium-tsExc4 : 12.65% ;
Lymphocytic choriomeningitis mammarenavirus
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Pallium-tsEG : 21.31% ;
Pallium-tsExc1 : 20.13% ;
Pallium-tsExc5 : 15.11% ;
Pallium-tsExc2 : 13.46% ;
Pallium-tsExc4 : 12.65% ;
Marburg marburgvirus
Pallium-tsExc1 : 58.47% ;
Pallium-tsExc4 : 46.24% ;
Pallium-tsExc5 : 41.97% ;
Pallium-tsExc3 : 36.75% ;
Pallium-tsEG : 29.12% ;
Hendra henipavirus
Pallium-tsExc3 : 58.46% ;
Pallium-tsExc1 : 45.76% ;
Pallium-tsNPCs : 42.12% ;
Pallium-tsExc5 : 38.72% ;
Pallium-tsExc4 : 30.74% ;
Pallium-tsExc3 : 12.97% ;
Nipah henipavirus
Pallium-tsExc3 : 58.46% ;
Pallium-tsExc1 : 45.76% ;
Pallium-tsNPCs : 42.12% ;
Pallium-tsExc5 : 38.72% ;
Pallium-tsExc4 : 30.74% ;
Pallium-tsExc3 : 12.97% ;
Foot-and-mouth disease virus
Pallium-tsExc1 : 57.20% ;
Pallium-tsOPC : 52.74% ;
Pallium-tsEG : 52.13% ;
Pallium-tsExc5 : 49.11% ;
Pallium-tsExc4 : 43.10% ;
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Human alphaherpesvirus 1
Pallium-tsExc1 : 57.20% ;
Pallium-tsOPC : 52.74% ;
Pallium-tsEG : 52.13% ;
Pallium-tsExc5 : 49.11% ;
Pallium-tsExc4 : 43.10% ;
Pallium-tsOlig : 20.00% ;
Pallium-tsExc3 : 12.22% ;
Pallium-tsExc1 : 12.08% ;
Pallium-tsExc2 : 11.74% ;
Pallium-doublets : 10.98% ;
Simian sarcoma-associated virus
Pallium-tsEG : 54.94% ;
Pallium-tsExc2 : 22.99% ;
Pallium-doublets : 20.12% ;
Pallium-tsExc5 : 19.72% ;
Pallium-tsExc3 : 18.42% ;
Gibbon ape leukemia virus
Pallium-tsEG : 54.94% ;
Pallium-tsExc2 : 22.99% ;
Pallium-doublets : 20.12% ;
Pallium-tsExc5 : 19.72% ;
Pallium-tsExc3 : 18.42% ;
Pallium-tsExc5 : 27.80% ;
Pallium-tsInh2 : 26.81% ;
Pallium-tsExc1 : 25.00% ;
Pallium-tsExc4 : 22.94% ;
Pallium-tsExc2 : 22.41% ;
Feline leukemia virus strain B/lambda-B1
Pallium-tsEG : 54.94% ;
Pallium-tsExc2 : 22.99% ;
Pallium-doublets : 20.12% ;
Pallium-tsExc5 : 19.72% ;
Pallium-tsExc3 : 18.42% ;
Pallium-tsExc5 : 27.80% ;
Pallium-tsInh2 : 26.81% ;
Pallium-tsExc1 : 25.00% ;
Pallium-tsExc4 : 22.94% ;
Pallium-tsExc2 : 22.41% ;
Mammalian orthoreovirus
Pallium-tsExc1 : 54.66% ;
Pallium-tsExc4 : 46.50% ;
Pallium-tsExc3 : 39.85% ;
Pallium-tsExc5 : 35.71% ;
Pallium-tsOPC : 23.47% ;
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Severe acute respiratory syndrome coronavirus 2
Pallium-tsExc2 : 51.15% ;
Pallium-tsMur : 27.19% ;
Pallium-doublets : 21.95% ;
Pallium-tsExc3 : 21.15% ;
Pallium-tsExc5 : 19.36% ;
Pallium-tsExc1 : 11.44% ;
Feline leukemia virus strain C/FA27
Pallium-tsExc2 : 40.56% ;
Pallium-tsExc5 : 37.78% ;
Pallium-tsExc1 : 35.59% ;
Pallium-tsInh2 : 35.09% ;
Pallium-tsExc4 : 34.41% ;
Ross River virus
Pallium-tsMur : 40.35% ;
Pallium-doublets : 11.59% ;
Onyong-nyong virus
Pallium-tsMur : 40.35% ;
Pallium-doublets : 11.59% ;
Mayaro virus
Pallium-tsMur : 40.35% ;
Pallium-doublets : 11.59% ;
Human metapneumovirus
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Equid alphaherpesvirus 1
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsMG : 15.96% ;
Pallium-doublets : 11.59% ;
Pallium-tsLeuB : 11.11% ;
Human betaherpesvirus 5
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsMur : 35.09% ;
Pallium-doublets : 12.80% ;
Human gammaherpesvirus 4
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Human rotavirus strain WA
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsEG : 26.90% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsLeuT : 11.11% ;
Pallium-tsMG : 9.85% ;
Human parvovirus B19
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Echovirus E1
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsEG : 26.90% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsLeuT : 11.11% ;
Pallium-tsMG : 9.85% ;
Echovirus E8
Pallium-tsOPC : 35.45% ;
Pallium-tsEG : 34.57% ;
Pallium-tsOlig : 33.55% ;
Pallium-tsLeuB : 25.00% ;
Pallium-tsNPCs : 23.29% ;
Pallium-tsEG : 26.90% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsLeuT : 11.11% ;
Pallium-tsMG : 9.85% ;
Human mastadenovirus A
Pallium-tsNPCs : 34.31% ;
Human mastadenovirus E
Pallium-tsNPCs : 34.31% ;
Human mastadenovirus C
Pallium-tsNPCs : 34.31% ;
Pallium-tsEG : 12.28% ;
Pallium-tsExc1 : 10.81% ;
Human mastadenovirus D
Pallium-tsNPCs : 34.31% ;
Human mastadenovirus F
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B6
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B2
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B4
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B3
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B1
Pallium-tsNPCs : 34.31% ;
Coxsackievirus B5
Pallium-tsNPCs : 34.31% ;
Vesicular stomatitis virus
Pallium-tsExc1 : 32.63% ;
Pallium-tsExc5 : 27.10% ;
Pallium-tsExc4 : 25.49% ;
Pallium-tsExc3 : 25.09% ;
Pallium-tsExc2 : 21.84% ;
Pallium-tsMG : 19.52% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsOlig : 14.19% ;
Pallium-doublets : 13.41% ;
Pallium-tsLeuT : 11.11% ;
Human alphaherpesvirus 3
Pallium-tsExc1 : 31.99% ;
Pallium-tsExc5 : 26.21% ;
Pallium-tsExc4 : 24.16% ;
Pallium-tsExc2 : 21.43% ;
Pallium-tsExc3 : 20.02% ;
Varicella Zoster Virus
Pallium-tsExc1 : 31.99% ;
Pallium-tsExc5 : 26.21% ;
Pallium-tsExc4 : 24.16% ;
Pallium-tsExc2 : 21.43% ;
Pallium-tsExc3 : 20.02% ;
Middle East respiratory syndrome-related coronavirus
Pallium-tsExc2 : 28.08% ;
Pallium-tsExc3 : 25.47% ;
Pallium-tsExc5 : 24.79% ;
Pallium-tsExc1 : 23.31% ;
Pallium-tsInh2 : 21.08% ;
Amphotropic murine leukemia virus
Pallium-tsExc5 : 27.80% ;
Pallium-tsInh2 : 26.81% ;
Pallium-tsExc1 : 25.00% ;
Pallium-tsExc4 : 22.94% ;
Pallium-tsExc2 : 22.41% ;
Xenotropic murine leukemia virus
Pallium-tsExc2 : 22.91% ;
Pallium-tsExc1 : 21.40% ;
Pallium-tsExc5 : 20.07% ;
Pallium-tsExc3 : 19.08% ;
Pallium-tsInh2 : 18.52% ;
Polytropic murine leukemia virus
Pallium-tsExc2 : 22.91% ;
Pallium-tsExc1 : 21.40% ;
Pallium-tsExc5 : 20.07% ;
Pallium-tsExc3 : 19.08% ;
Pallium-tsInh2 : 18.52% ;
Ecotropic murine leukemia virus
Pallium-tsExc1 : 22.03% ;
Pallium-tsExc3 : 19.74% ;
Pallium-tsExc2 : 19.70% ;
Pallium-tsExc5 : 18.89% ;
Pallium-tsExc4 : 17.80% ;
Oliveros mammarenavirus
Pallium-tsEG : 21.31% ;
Pallium-tsExc1 : 20.13% ;
Pallium-tsExc5 : 15.11% ;
Pallium-tsExc2 : 13.46% ;
Pallium-tsExc4 : 12.65% ;
Latino mammarenavirus
Pallium-tsEG : 21.31% ;
Pallium-tsExc1 : 20.13% ;
Pallium-tsExc5 : 15.11% ;
Pallium-tsExc2 : 13.46% ;
Pallium-tsExc4 : 12.65% ;
Human alphaherpesvirus 2
Pallium-tsOlig : 20.00% ;
Pallium-tsExc3 : 12.22% ;
Pallium-tsExc1 : 12.08% ;
Pallium-tsExc2 : 11.74% ;
Pallium-doublets : 10.98% ;
Human rhinovirus A2
Pallium-tsMG : 19.52% ;
Pallium-tsLeuB : 19.44% ;
Pallium-tsOlig : 14.19% ;
Pallium-doublets : 13.41% ;
Pallium-tsLeuT : 11.11% ;
Human gammaherpesvirus 8
Pallium-tsOlig : 15.48% ;
Canine parvovirus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Feline panleukopenia virus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Pallium-tsExc3 : 9.68% ;
Machupo mammarenavirus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Argentinian mammarenavirus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Guanarito mammarenavirus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Canine morbillivirus
Pallium-tsLeuT : 13.89% ;
Mouse mammary tumor virus
Pallium-tsLeuB : 13.89% ;
Pallium-tsExc1 : 11.02% ;
Pallium-tsExc5 : 10.09% ;
Pallium-tsExc3 : 9.68% ;
Rinderpest morbillivirus
Pallium-tsLeuT : 13.89% ;
Measles morbillivirus
Pallium-tsLeuT : 13.89% ;
Phocine morbillivirus
Pallium-tsLeuT : 13.89% ;
Feline endogenous virus RD114
Pallium-tsExc1 : 12.71% ;
Pallium-tsExc5 : 12.22% ;
Pallium-tsExc3 : 10.53% ;
Pallium-tsExc2 : 9.93% ;
Baboon endogenous virus strain M7
Pallium-tsExc1 : 12.71% ;
Pallium-tsExc5 : 12.22% ;
Pallium-tsExc3 : 10.53% ;
Pallium-tsExc2 : 9.93% ;
Simian type D retrovirus -Tsukuba
Pallium-tsExc1 : 12.71% ;
Pallium-tsExc5 : 12.22% ;
Pallium-tsExc3 : 10.53% ;
Pallium-tsExc2 : 9.93% ;
Simian immunodeficiency virus
Pallium-tsLeuT : 11.11% ;
Human betaherpesvirus 7
Pallium-tsLeuT : 11.11% ;
Japanese encephalitis virus
Pallium-tsLeuB : 11.11% ;
Hepatitis E virus
Pallium-tsExc4 : 10.25% ;
Pallium-tsExc5 : 9.74% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China